$XNCR stock is up 13% today. Here's what we see in our data. - Quiver Quantitative
Yesterday • Google News
Xencor Inc (XNCR)
US$ 10.51-3.04%
Price Chart
Key Statistics
Market Cap
$ 660.47M
P/E Ratio
0.00
Revenue (TTM)
$ 127.23M
Volume
455.27K
52W High
$ 27.24
52W Low
$ 7.16
Dividend Yield
0.00%
Beta
0.87
Technicals
50-Day MA
8.7166
200-Day MA
16.1011
52 Week High
27.24
52 Week Low
7.16
About XNCR
Xencor, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibodies for the treatment of asthma and allergic diseases, autoimmune dis.
Employees
250
Headquarters
Pasadena, CA
CEO
Dr. Bassil I. Dahiyat Ph.D.
Latest News
Will Xencor (XNCR) Report Negative Q1 Earnings? What You Should Know - Yahoo Finance
2025-05-01 • Google News
(XNCR) Investment Analysis - news.stocktradersdaily.com
2 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg